SCHEMBL13628671

SCHEMBL13628671

CC(C)NOCCCc1ccccn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.49
ALDH1A1 P00352 2/20 0.49
CYP2C19 P33261 2/20 0.49
HRH3 Q9Y5N1 2/20 0.47
HRH1 P35367 2/20 0.46
LMNA P02545 2/20 0.46
TAAR1 Q96RJ0 1/20 0.46
ALOX15 P16050 1/20 0.46
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
APP P05067 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12530835 0.79 HRH1 (0.50) CYP1A2ALDH1A1CYP2C19HRH3HRH1
SCHEMBL6859512 0.76 HRH1 (0.55) CYP1A2ALDH1A1CYP2C19HRH3HRH1
SCHEMBL7445422 0.76 HRH1 (0.58) CYP1A2ALDH1A1CYP2C19HRH3HRH1
SCHEMBL10240776 0.76 CYP1A2 (0.57) CYP1A2ALDH1A1CYP2C19HRH3HRH1
SCHEMBL29485637 0.73 HRH1 (0.69) CYP1A2ALDH1A1CYP2C19HRH3HRH1
SCHEMBL726512 0.73 HRH1 (0.76) CYP1A2ALDH1A1CYP2C19HRH3HRH1
SCHEMBL231470 0.73 HRH1 (0.69) CYP1A2ALDH1A1CYP2C19HRH3HRH1
SCHEMBL147199 0.73 CYP3A4 (0.61) CYP1A2ALDH1A1CYP2C19HRH3HRH1
SCHEMBL28601548 0.73 HRH1 (0.55) CYP1A2ALDH1A1CYP2C19HRH3HRH1
SCHEMBL12604331 0.73 CYP1A2 (0.57) CYP1A2ALDH1A1CYP2C19HRH3HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612197-B2 Reacting a nucleophil with OH group with an electrophil to form an adduct, reacting adduct with a reagent selected from oxidizing, sulfurizing or selenizing agents to produce hydroxy protected oligonucleotide, heating to deprotect hydroxy protecting group such as 2-(2-pyridyl)aminoethoxycarbonyl The United States of America as repesented by the Secretary of the Department of Health and Human Services (US) 2009-11-03 US disclosed